Prelude Therapeutics to Participate in Citizens Life Sciences Conference
Provided By GlobeNewswire
Last update: May 1, 2025
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025.
Read more at globenewswire.comNASDAQ:PRLD (11/18/2025, 1:05:03 PM)
1.67
+0.02 (+1.21%)
Find more stocks in the Stock Screener
PRLD Latest News and Analysis
6 days ago - By: Chartmill
